Posted by Chairman_MAO on August 31, 2005, at 16:49:10
In reply to Re: To Chairman_MAO, posted by denise1966 on August 31, 2005, at 6:50:52
It affects monoamine oxidase type A and B, which are responsible for the catabolism (breaking down) of serotonin and norepinephrine, and dopamine (type A), and dopamine and trace amines (type B).
When type A is inhibited by 80%, some profoundly antidepressant and anxiolytic effect occurs as a result of the CNS bringing itself back to homeostatis with the increased levels of neurotransmitter in the synaptic clefts.
The reuptake pumps are unaffected. Neuropsychopharm studies show that increased levels of MAO-A are present in those with anxiety and phobic states.
poster:Chairman_MAO
thread:548105
URL: http://www.dr-bob.org/babble/20050827/msgs/549307.html